Skip navigation
home

Changes in drug coverage at MIT Pharmacy

The MIT Pharmacy and the MIT Health Plans have announced changes in coverage for several prescription drugs:

  • Nasonex, a nasal spray used to treat seasonal allergies and other nasal symptoms, is no longer on the MIT formulary. MIT Pharmacy staff will work with providers to switch patients to a formulary medication.
  • Fexofenadine (a non-sedating antihistamine) will no longer be covered by the MIT Health Plan. The MIT Pharmacy will continue to dispense fexofenadine with a prescription at the retail price, as well as several over-the-counter alternatives such as loratadine and cetirizine.
  • The MIT Health Plan now allows plan members to purchase a three-month supply of Viagra at the MIT Pharmacy. However, Viagra does not qualify for the three-for-two program (three month’s supply for a two-month copay amount), so patients are subject to three copays when they purchase a three-month supply.
  • The ProAir inhaler (albuterol for asthma) is now Tier 2. The generic albuterol inhaler is no longer available.

In addition, patients requesting brand-name medications rather than generics without  documented clinical reasons will be charged the full retail price for that prescription.

Feb. 5, 2009

Contact

MIT Pharmacy
Phone: 617-253-1324
E23-main floor
Hours: M–Th, 8:30 a.m. to 7 p.m.; F, 8:30 a.m. to 5:30 p.m.

MIT Health Plans
Prescription Drugs

Claims and Member Services
E23-191
617-253-5979

Phone Hours
M–F, 8:30 a.m. to 5 p.m.

Walk-in Hours
M–F, 9 a.m. to 5 p.m